file,ref_number,ref_text,doi,doi_url,titleDoi,firstAuthDoi,author_similarity,title_similarity
experiments/glioblastoma_survival/ai_messages/high_complexity--generated_EGFR_MGMT_low_methylated,[1],"Brennan CW, et al. 2013. Cell. The somatic genomic landscape of glioblastoma.",10.7717/peerj.13105/table-1,https://doi.org/10.7717/peerj.13105/table-1,"Table 1: Crown width-DBH (CW-D) candidate functions considered in the analysis (Fu et al., 2013; Raptis et al., 2018; Wang et al., 2021).",,0,43
experiments/glioblastoma_survival/ai_messages/high_complexity--generated_EGFR_MGMT_low_methylated,[2],"Hegi ME, et al. 2005. N Engl J Med. MGMT gene silencing and benefit from temozolomide in glioblastoma.",10.3410/f.718384246.793495041,https://doi.org/10.3410/f.718384246.793495041,Faculty Opinions recommendation of MGMT gene silencing and benefit from temozolomide in glioblastoma.,Gilbert,10,80
experiments/glioblastoma_survival/ai_messages/high_complexity--generated_EGFR_MGMT_low_methylated,[3],"Stupp R, et al. 2005. N Engl J Med. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma.",10.1097/01.cot.0000289242.47980.f9,https://doi.org/10.1097/01.cot.0000289242.47980.f9,“Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma”,Stupp,100,100
